
US industry organisations including the Pharmaceutical Research and Manufacturers of America (PhRMA) have launched legal action against the Trump administration …

There is a duty to ensure access to innovative treatments for patients with unmet need, but a health service gatekeeper …

The introduction of a generic medicine should, in theory, incentivise companies to lower the price of the original drug, creating healthy …

Brand name prescription drugs cost on average 4.3 times more in the United States than in the UK, according to …

The impasse over access to Vertex’s Orkambi for cystic fibrosis patients in England and Wales has revealed the cracks in …

Just one month to go until Brexit here in the UK, and it’s still all to play for. After months …

Two weeks before the all-important midterm elections in the US, and after repeated strongly-worded promises, President Trump has unveiled an …

US Health and Human Services Secretary Alex Azar, has announced a proposal which would require pharma firms to include the …

A new group, organised under the banner of the Alliance to Protect Medical Innovation, is blaming hospitals and PBM’s for …

A ruling which would force pharmaceutical companies to disclose the price of their drugs in television advertisements has been set …

The American pharmaceutical industry trade lobby PhRMA has suggested that hospitals are to blame for high drug prices as the …

The FDA has been directed to explore ways in which medicines could be safely imported from other countries “in the …

Price hiking in the pharmaceutical industry continues to persist, and has become ever more prominent in the public sphere thanks …

President Trump’s rhetoric leading up to his election had the pharmaceutical industry very worried – his often quoted line about …

The state of California has become the target of legal action after the lobbying group Pharmaceutical Research and Manufacturers of …